← Back to Products
Semaglutide

Semaglutide

1mg

Semaglutide is an advanced compound used in type 2 diabetes management. It belongs to the incretin hormone class and supports the pancreas in insulin synthesis, contributes to glucose level reduction, and stimulates metabolic processes. This next-generation peptide effectively regulates blood sugar levels and helps normalize body weight. Semaglutide demonstrates potential in supporting diabetes management while showing positive effects on overall health. It can be combined with other diabetes management approaches, enhancing their effectiveness and contributing to improved quality of life. The compound exhibits beneficial effects on body weight regulation by supporting appetite suppression and promoting satiety. It also contributes to improvements in blood pressure and cholesterol levels, potentially reducing cardiovascular risks.

Key Benefits

  • Supports insulin production and glucose regulation.
  • Enhances liver function and reduces fat accumulation risks.
  • Helps control blood sugar levels, reducing diabetes-related complication risks.
  • Suppresses appetite and promotes satiety for healthy weight management.
  • Stimulates insulin secretion from the pancreas when glucose levels are elevated.
  • Assists in maintaining glucose control while minimizing hypoglycemia risk.
  • Supports cardiovascular health improvements.

Clinical Research

Semaglutide has successfully completed comprehensive clinical trials demonstrating high efficacy and safety in participants with type 2 diabetes. The SUSTAIN 6 study, which included 3,000 participants with diabetes, showed that Semaglutide use significantly reduced the risk of cardiovascular incidents and stroke. Additional clinical trials have proven the compound's positive influence on glucose level reduction, insulin secretion stimulation, improved glycemic control, and healthy weight regulation in participants.

Usage & Dosage

Administration & Dosage
  • Dosage of Semaglutide depends on individual conditions; consultation with a qualified specialist is recommended for proper dose determination and administration method.
  • Administered via subcutaneous injection once weekly.
  • Initial dose is typically 0.25mg, which may be increased to 0.5mg or 1mg depending on needs.
  • If a dose is missed, it should be administered as soon as possible, but double doses should not be taken.
Injection Guide
  1. Inject in the abdominal area or front of the thigh.
  2. After injection, wait 10 seconds before removing the needle.
  3. Rotation of injection sites is recommended.
Dose Reference
10 units = 0.25mg20 units = 0.50mg40 units = 1mg25 units = 0.25mg50 units = 0.5mg

Possible Side Effects

Semaglutide is a peptide commonly studied for its effects on metabolic function and blood glucose regulation. As with any compound, some individuals may experience side effects, particularly if used incorrectly or at inappropriate dosages.

Reported side effects may include:

  • Headache
  • Nausea
  • Diarrhea
  • Constipation
  • Mild skin irritation or itching around the injection site

These effects are generally mild and temporary, often resolving within a few days. Following recommended dosing protocols and professional guidance may help reduce the likelihood of unwanted reactions.

Proper Storage

It is recommended that the products are stored at temperatures between 2°C and 8°C in a refrigerator.

Disclaimer

This content is provided for informational purposes only and does not constitute medical advice. The products referenced here are intended strictly for laboratory, scientific, and research use. Always consult a qualified healthcare professional before considering any use or application of these products.